Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study
Clinical trial NCT00076440 · COMPLETED
Trial details
- NCT number
- NCT00076440
- Sponsor
- Voyager Pharmaceutical Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2007-03-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.